{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:41:17Z","timestamp":1792636877478,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CDR-1511-33496"],"award-info":[{"award-number":["CDR-1511-33496"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Racial disparities in opioid prescriptions for pain are well documented. Evidence shows undertreated acute pain increases the risk of developing chronic pain, which\u00a0puts patients at risk of long-term opioid use and misuse. We sought to determine the association between satisfaction with analgesia, unmet opioid preference, and opioid misuse risk by race in a diverse, longitudinal cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a secondary analysis of participants with complete data in an RCT of 1301 patients who presented to the emergency department (E.D.) for acute kidney or back pain. Our primary outcome was opioid misuse risk quantified by the current opioid misuse measure (COMM), a self-report 17-item measure of risk of aberrant medication-related behavior among persons prescribed opioids for chronic pain, measured 90\u00a0days after the index E.D. visit. We used descriptive statistics and linear regressions to determine associations between satisfaction with analgesia (1\u201310, measured 1-day post-visit), unmet opioid preference, and opioid misuse risk by race, adjusting for age and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We analyzed 735 participants. The mean (SD) age was 39.6 (13.6), 58.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009432) were female, 46.4%(\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009341) were White, and 36.9%(\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009271) were Black. Unmet preference was more common among Black (21.8%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200959) vs. White (15%,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200951) participants. Black (vs White) participants had a higher median (IQR) COMM (4 (1 \u2013 12) vs 3 (1 \u2013 6),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, and lower median satisfaction (7 (4\u201310) vs 8 (5 \u2013 10),\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). Adjusting for unmet preference and satisfaction, Black (vs. White) participants had higher COMM (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20093.4, 95% CI 1.6\u20135.3,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01). Unmet preference was associated with higher COMM (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20092.3, 95% CI 1.3\u20133.2,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Satisfaction was associated with lower COMM (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009= \u2212\u20090.5\u00a0pp, 95% CI\u2009\u2212\u20090.7,\u2009\u2212\u20090.2,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). In a model with a triple interaction between satisfaction, unmet preference, and race, satisfaction was associated with lower COMM (\u2212\u20090.3\u00a0pp, 95% CI\u2009\u2212\u20090.5,\u2009\u2212\u20090.1,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) and mitigated the effect of unmet preference on Black participants\u2019 COMM (marginal effect\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009= \u2212\u20091.3\u00a0pp, 95% CI\u2009\u2212\u20091.9,\u2009\u2212\u20090.7,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Satisfaction with analgesia was protective against opioid misuse risk, especially among Black participants whose opioid preference was unmet. Addressing unmet preferences and understanding factors that shape patient satisfaction with analgesia could help reduce racial disparities in opioid misuse.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-09637-w","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T12:02:14Z","timestamp":1750852934000},"page":"1041-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Racial Disparities in Unmet Pain Treatment Preference, Pain Treatment Satisfaction\u00a0and\u00a0Subsequent Opioid Misuse: A Secondary Analysis of a National Multisite RCT"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-8926","authenticated-orcid":false,"given":"Max Jordan","family":"Nguemeni Tiako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden","family":"Engel-Rebitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Shofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik P.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn M.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary F.","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"3","key":"9637_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1526-4637.2003.03034.x","volume":"4","author":"CR Green","year":"2003","unstructured":"Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: Confronting racial and ethnic disparities in pain. Pain Medicine. 2003;4(3):277-294. https:\/\/doi.org\/10.1046\/j.1526-4637.2003.03034.x","journal-title":"Pain Medicine."},{"issue":"5","key":"9637_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1176\/appi.ajp.20230917","volume":"181","author":"J Friedman","year":"2024","unstructured":"Friedman J, Nguemeni Tiako MJ, Hansen H. Understanding and Addressing Widening Racial Inequalities in Drug Overdose. American Journal of Psychiatry. 2024;181(5):381-390.","journal-title":"American Journal of Psychiatry."},{"issue":"4","key":"9637_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/JAMAPSYCHIATRY.2022.0004","volume":"79","author":"JR Friedman","year":"2022","unstructured":"Friedman JR, Hansen H. Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2022;79(4):379-381. https:\/\/doi.org\/10.1001\/JAMAPSYCHIATRY.2022.0004","journal-title":"JAMA Psychiatry."},{"key":"9637_CR4","doi-asserted-by":"publisher","unstructured":"Zhang H, Kilaru AS, Meisel ZF, Bao Y. Prescription Drug Monitoring Program Mandates and Opioids Dispensed following Emergency Department Encounters for Patients with Sickle Cell Disease or Cancer with Bone Metastasis. JAMA - Journal of the American Medical Association. Published online 2021. https:\/\/doi.org\/10.1001\/jama.2021.10161","DOI":"10.1001\/jama.2021.10161"},{"key":"9637_CR5","unstructured":"A \u2018Rare Case Where Racial Biases\u2019 Protected African-Americans - The New York Times. Accessed April 28, 2021. https:\/\/www.nytimes.com\/2019\/11\/25\/upshot\/opioid-epidemic-blacks.html"},{"issue":"9","key":"9637_CR6","doi-asserted-by":"publisher","first-page":"e212333","DOI":"10.1001\/JAMAHEALTHFORUM.2021.2333","volume":"2","author":"DP Ly","year":"2021","unstructured":"Ly DP. Association of Patient Race and Ethnicity With Differences in Opioid Prescribing by Primary Care Physicians for Older Adults With New Low Back Pain. JAMA Health Forum. 2021;2(9):e212333-e212333. https:\/\/doi.org\/10.1001\/JAMAHEALTHFORUM.2021.2333","journal-title":"JAMA Health Forum."},{"issue":"1","key":"9637_CR7","first-page":"1","volume":"6","author":"T Shippee","year":"2013","unstructured":"Shippee T, Henning-Smith C, Shippee N, et al. Discrimination in medical settings and attitudes toward complementary and alternative medicine: The role of distrust in conventional providers. J Health Dispar Res Pract. 2013;6(1):1-16.","journal-title":"J Health Dispar Res Pract."},{"issue":"4","key":"9637_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00127-016-1174-y","volume":"51","author":"H Carliner","year":"2016","unstructured":"Carliner H, Delker E, Fink DS, Keyes KM, Hasin DS. Racial discrimination, socioeconomic position, and illicit drug use among US Blacks. Soc Psychiatry Psychiatr Epidemiol. 2016;51(4):551-560. https:\/\/doi.org\/10.1007\/s00127-016-1174-y","journal-title":"Soc Psychiatry Psychiatr Epidemiol."},{"key":"9637_CR9","doi-asserted-by":"publisher","first-page":"107958","DOI":"10.1016\/j.drugalcdep.2020.107958","volume":"210","author":"SM Silverstein","year":"2020","unstructured":"Silverstein SM, Daniulaityte R, Miller SC, Martins SS, Carlson RG. On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine. Drug Alcohol Depend. 2020;210:107958-107958.","journal-title":"Drug Alcohol Depend."},{"issue":"71","key":"9637_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.drugpo.2019.06.019","volume":"2019","author":"K McLean","year":"2019","unstructured":"McLean K, Kavanaugh PR. \u201cThey\u2019re making it so hard for people to get help:\u201d Motivations for non-prescribed buprenorphine use in a time of treatment expansion. International Journal of Drug Policy. 2019;71(2019):118-124. https:\/\/doi.org\/10.1016\/j.drugpo.2019.06.019","journal-title":"International Journal of Drug Policy."},{"key":"9637_CR11","doi-asserted-by":"crossref","unstructured":"Meisel Z, Shofer F, Dolan A, et al. Multicentered Randomized Controlled Trial Comparing the Effectiveness of Pain Treatment Communication Tools in Emergency Department Patients with Back Pain or Kidney Stone Pain. Am J Public Health. 2021;In Press.","DOI":"10.2105\/AJPH.2021.306511"},{"issue":"7","key":"9637_CR12","doi-asserted-by":"publisher","first-page":"e2118801","DOI":"10.1001\/JAMANETWORKOPEN.2021.18801","volume":"4","author":"E Engel-Rebitzer","year":"2021","unstructured":"Engel-Rebitzer E, Dolan AR, Aronowitz S V., et al. Patient Preference and Risk Assessment in Opioid Prescribing Disparities: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021;4(7):e2118801-e2118801. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2021.18801","journal-title":"JAMA Netw Open."},{"key":"9637_CR13","doi-asserted-by":"publisher","unstructured":"Nguemeni Tiako M, Shofer F, Dolan A, et al. Personalized Risk Communication and Opioid Prescribing In Association With Non-Prescribed Opioid Use: A Secondary Analysis of a Randomized Controlled Trial. Academic emergency Medicine. Published online 2023:0\u20132. https:\/\/doi.org\/10.1111\/acem.14710","DOI":"10.1111\/acem.14710"},{"issue":"9","key":"9637_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/19496","volume":"9","author":"ZF Meisel","year":"2020","unstructured":"Meisel ZF, Goldberg EB, Dolan AR, et al. Stories to communicate individual risk for opioid prescriptions for back and kidney stone pain: Protocol for the life storried multicenter randomized clinical trial. JMIR Res Protoc. 2020;9(9):1-16. https:\/\/doi.org\/10.2196\/19496","journal-title":"JMIR Res Protoc."},{"key":"9637_CR15","unstructured":"Way To Health."},{"key":"9637_CR16","unstructured":"Institute on Drug Abuse N. Opioid Risk Tool."},{"issue":"9","key":"9637_CR17","doi-asserted-by":"publisher","first-page":"e19496","DOI":"10.2196\/19496","volume":"9","author":"ZF Meisel","year":"2020","unstructured":"Meisel ZF, Goldberg EB, Dolan AR, et al. Stories to Communicate Individual Risk for Opioid Prescriptions for Back and Kidney Stone Pain: Protocol for the Life STORRIED Multicenter Randomized Clinical Trial. JMIR Res Protoc. 2020;9(9):e19496. https:\/\/doi.org\/10.2196\/19496","journal-title":"JMIR Res Protoc."},{"issue":"1","key":"9637_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AJP.0b013e3181f195ba.Cross","volume":"23","author":"SF Butler","year":"2008","unstructured":"Butler SF, Budman S, Fanciulo GJ, Jamison RN. Cross Validation of the Current Opioid Misuse Measure (COMM) to Monitor Chronic Pain Patients on Opioid Therapy. Clinical. 2008;23(1):1-7. https:\/\/doi.org\/10.1097\/AJP.0b013e3181f195ba.Cross","journal-title":"Clinical."},{"issue":"5","key":"9637_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2105\/AJPH.2011.300558","volume":"102","author":"LA Cooper","year":"2012","unstructured":"Cooper LA, Roter DL, Carson KA, et al. The associations of clinicians\u2019 implicit attitudes about race with medical visit communication and patient ratings of interpersonal care. Am J Public Health. 2012;102(5):979-987. https:\/\/doi.org\/10.2105\/AJPH.2011.300558","journal-title":"Am J Public Health."},{"key":"9637_CR20","doi-asserted-by":"publisher","unstructured":"Swift SL, Glymour MM, Elfassy T, et al. Racial discrimination in medical care settings and opioid pain reliever misuse in a U.S. cohort: 1992 to 2015. Green KM, ed. PLoS One. 2019;14(12):e0226490. https:\/\/doi.org\/10.1371\/journal.pone.0226490","DOI":"10.1371\/journal.pone.0226490"},{"key":"9637_CR21","doi-asserted-by":"publisher","first-page":"107958","DOI":"10.1016\/J.DRUGALCDEP.2020.107958","volume":"210","author":"SM Silverstein","year":"2020","unstructured":"Silverstein SM, Daniulaityte R, Miller SC, Martins SS, Carlson RG. On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine. Drug Alcohol Depend. 2020;210:107958. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2020.107958","journal-title":"Drug Alcohol Depend."},{"key":"9637_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.JSAT.2015.04.010","volume":"57","author":"LB Monico","year":"2015","unstructured":"Monico LB, Mitchell SG, Gryczynski J, et al. Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention. J Subst Abuse Treat. 2015;57:57-62. https:\/\/doi.org\/10.1016\/J.JSAT.2015.04.010","journal-title":"J Subst Abuse Treat."},{"key":"9637_CR23","doi-asserted-by":"publisher","unstructured":"Nguemeni Tiako MJ. Addressing Racial & Socioeconomic Disparities in Access to Medications for Opioid Use Disorder Amid COVID-19. J Subst Abuse Treat. 2020;0(0):108214. https:\/\/doi.org\/10.1016\/j.jsat.2020.108214","DOI":"10.1016\/j.jsat.2020.108214"},{"issue":"February","key":"9637_CR24","doi-asserted-by":"publisher","first-page":"110819","DOI":"10.1016\/j.drugalcdep.2023.110819","volume":"249","author":"J Friedman","year":"2023","unstructured":"Friedman J, Godvin M, Molina C, et al. Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study. Drug Alcohol Depend. 2023;249(February):110819. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.110819","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20132","key":"9637_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pain.2007.01.014","volume":"130","author":"SF Butler","year":"2007","unstructured":"Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130(1-2):144-156. https:\/\/doi.org\/10.1016\/j.pain.2007.01.014","journal-title":"Pain."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09637-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:25:44Z","timestamp":1774283144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09637-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9637"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09637-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The study was approved by the University of Pennsylvania Institutional Review Board. All participants provided their consent to participate in the study to a research assistant in charge of recruitment and enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate:"}},{"value":"The authors declare that they do not have a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}}]}}